4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-049070
Chief Commercial Officer bought 1,200 shares at $6.48 ($7,776)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reiter Sarah Chief Commercial Officer | 2019-09-10 | Purchase | +1,200 | $6.48 | $7,776 | 1,200 | D |
| Open-market purchases · 1,200 sh · avg $6.48 · $7,776 | |||||||
Loading xslF345X03/doc4.xml…